Morning Breakouts

Latest California Healthline Stories

The Shining Promise Of Precision Medicine Often Disappoints, But Hope Remains

For cancer patients enrolled in precision medicine trials, the results are often underwhelming because the technique is just not precise enough yet. But, still, it offers a tantalizing glimpse of what could be possible.

Hedge Fund Suggests Channeling Olive Garden To Revamp ‘Undervalued’ Drug Company

Starboard Value is calling for a special meeting of Depomed’s shareholders to replace the board of the drugmaker because it “lacks the leadership, objectivity and perspective to act in the best interests of shareholders.”

Judge Denies Request To Tweak Report On Drug Price Transparency Initiative

A consumer activist wanted to add a sentence to a state report on the ballot measure to counter any “scare tactics” from opponents that would suggest the initiative could cause drug prices for veterans to rise. The judge, however, said he found nothing misleading about the current language.